Phase 3 COPD Trial, Recruiting NCT06376994 Sponsor: JHSPH Center for Clinical Trials Condition: COPD
Back to Copd

Phase 3 COPD Trial, Recruiting

NCT06376994
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 40 years of age or older
  • People who have been told by a doctor that they have COPD (a lung condition that makes it hard to breathe)
  • People whose breathing test results confirm a specific type of airway blockage, measured using a lung function test called spirometry (confirm with trial site for exact test values)
  • People who have smoked at least 10 "pack-years" of regular cigarettes — this means, for example, smoking one pack a day for 10 years, or two packs a day for 5 years (this does not include vaping or e-cigarettes)
  • People who stopped smoking regular cigarettes at least 6 months ago (e-cigarette use does not count as quitting)
  • People whose COPD significantly affects their daily life, shown by scoring at least 10 on a COPD symptom questionnaire, rating their breathlessness as fairly severe on a standard scale, or having had a moderate or severe COPD flare-up in the past 12 months (such as needing steroids or antibiotics for breathing problems, or visiting an emergency department or hospital for COPD)

Who may not be able to join:

  • People who live somewhere other than their own home, such as a nursing home or long-term care facility
  • People who have other ongoing lung diseases, with the exception of asthma
  • People who have a condition that is expected to be life-limiting within the next year, such as advanced cancer, or who are receiving hospice care
  • People who spend more than 2 months per year away from their home, or who plan to move within the next 12 months
  • People who are pregnant or breastfeeding
  • People who currently use an air cleaner in their home — although the trial site may still consider someone eligible if they are willing to stop using it and meet all other criteria
  • People who are unable to have air cleaners (each weighing around 15 pounds) brought into their home, whether by themselves or with the help of a friend or family member
  • People who the study team believes would have difficulty completing the study, including those unlikely to have reliable internet access
  • People who are already taking part in another clinical trial that involves a treatment or intervention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: (410) 502-3872

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
JHSPH Center for Clinical Trials
Registry
ClinicalTrials.gov
Start date
24 May 2024
Est. completion
31 August 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

St. George's Respiratory Questionnaire (SGRQ)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov